Newly available CAR T-cell therapy cuts cancer treatment cost by 90%
22 May 2025 02:00
ABU DHABI (ALETIHAD)Burjeel Medical City in Abu Dhabi has announced a major medical breakthrough with the development of an innovative CAR T-cell therapy for blood cancers, which could reduce treatment costs by up to 90 percent.This advancement marks a significant step towards localising biopharmaceutical industries, reinforcing the UAE's position as a regional hub for cellular therapies and medical innovation, while also enhancing healthcare and economic security.Speaking to Emirates News Agency (WAM) on the sidelines of the Make it in the Emirates forum at the Abu Dhabi National Exhibition Centre (ADNEC), Dr. Ajlan Al Zaki, Director of the Centre for Haematology, Oncology and Cellular Therapy at Burjeel Hospital in Abu Dhabi, described the event as an ideal platform to introduce this advanced treatment.The therapy involves collecting T-cells from the patient, genetically modifying them in a laboratory to recognise and attack cancer cells, then reinfusing them into the patient's body.Al Zaki said the forum offers a strategic opportunity to showcase the UAE's capabilities in locally manufacturing CAR T-cells and exploring export potential for this technology to regional and international markets. He noted that this approach exemplifies the integration of science and biotechnology, supporting the knowledge economy and building a sustainable healthcare ecosystem.He highlighted that the hospital's success in reducing treatment costs by up to 90 percent is unprecedented in the region, and strengthens the UAE's standing as a regional centre for advanced therapies. The achievement also paves the way for greater global scientific collaboration and reflects the country's significant progress in the medical field.Al Zaki, who previously held research and clinical roles at Stanford University and the MD Anderson Cancer Center, expressed his commitment to leveraging his expertise to provide effective and affordable cancer treatments across the UAE and the wider region, while raising awareness of CAR T-cell therapy for difficult-to-treat blood cancers.He explained that CAR T-cell therapy is a form of personalised, precision medicine usually administered in a single session, with promising recovery rates. This represents a paradigm shift in the future of cancer care in the UAE, and strengthens Abu Dhabi's role as a regional centre for clinical research and cancer treatment innovation.The CAR T-cell initiative, he added, demonstrates the UAE's capacity to localise advanced biotechnologies, empower national talent, and bridge scientific research with precision medicine and personalised therapies.While the treatment was initially designed for blood cancers such as leukaemia and lymphoma, research is expanding its application to solid tumours, including breast, pancreatic and lung cancers, as well as complex brain tumours like glioblastoma and metastatic cancers resistant to conventional therapies.Al Zaki also emphasised the growing role of artificial intelligence in genomic analysis and precise molecular target identification, along with the use of cutting-edge gene editing tools like CRISPR to enhance cell engineering.
He pointed to the UAE's collaborative efforts with scientific partners and non-profit institutions such as Caring Cross to manufacture these therapies locally, helping to make them more widely accessible across regional medical centres, rather than limited to a handful of global facilities.
Source: Aletihad - Abu Dhabi
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
10 hours ago
- Al Etihad
ADAFSA Reference Centre for Camel Diseases leads UAE to global prominence in camel health research on World Camel Day
22 June 2025 17:25 ABU DHABI (WAM)In celebration of World Camel Day on June 22, 2025, global attention turns to the historical, economic and cultural significance of camels—especially within the Middle East and Gulf region. This annual event aligns with global efforts to advance veterinary care for camels, strengthen biosecurity, and sustain the camel-rearing sector, which is vital to food Dhabi and the UAE have affirmed their leadership in this domain through the ADAFSA Reference Centre for Camel Diseases, officially recognised by the World Organisation for Animal Health (WOAH) in May 2022 as the first centre of its kind dedicated to camel this occasion, ADAFSA announced that the Centre has delivered a landmark series of scientific achievements, establishing approximately 200 advanced laboratory assays, processing over 300,000 camel samples, and providing more than one million diagnosis services—highlighting its advanced diagnostic capabilities and readiness to address disease outbreaks and emergencies. The Centre has performed whole-genome sequencing on 50 pathogens to identify virulent strains, enabling authorities to implement targeted disease control measures. It has also submitted 47 new genomic sequences to a global gene bank, reinforcing the UAE's position in camel disease a groundbreaking discovery, the Centre's experts became the first globally to detect the Wesselsbron virus (WSLV) in clinical and post-mortem samples from Ethiopian camels—a breakthrough that may explain mysterious camel fatalities over the past two findings were unveiled at the 26th African Regional Conference of WOAH, attended by senior officials and international delegates, further enhancing the Centre's and UAE's reputation in epidemiological diagnostics and global with cutting-edge molecular biology, full-genome sequencing, and bioinformatics platforms, the Centre supports early detection of infectious agents and provides diagnostic advisory services to the Gulf Cooperation Council (GCC) countries, Yemen, Iraq, Jordan, and other nations engaged in camel bolster its role, the Centre has launched the UAE's first biobank following global standards, storing over one million biological specimens, including reference material and specialised cells for camel and other animal disease diagnostics. The biobank supports the development of diagnostic reagents and kits, informs early-warning vaccine research, safeguards genetic diversity, and facilitates future disease preparedness Centre also leads a regional capacity-building initiative by delivering annual proficiency testing programmes, aligned with ISO/IEC 17025 standards, involving 33 regional and international laboratories from Saudi Arabia, Kuwait, Bahrain, Sudan, Jordan, Syria, and Italy. Additionally, it has organised over 20 training workshops and lectures for veterinarians, students, and researchers, and participated in more than 45 scientific conferences nationally and internationally. Its experts serve on WOAH technical committees, offering guidance on camel diseases such as trypanosomiasis, reinforcing its leadership in setting global biosecurity has also developed the Camel Health Network for the Middle East ("CAMNET"), a platform for collaboration across the Gulf, Jordan, Yemen, and Iraq. CAMNET has trained over 500 personnel to enhance regional veterinary laboratory quality. The Centre produced educational kits covering pathological anatomy, parasitology, and bacteriology, distributed to member countries to support veterinary education and field Centre has introduced the world's first proficiency-testing scheme for small ruminant pox virus assays in camels, in partnership with France's reference laboratory (CIRAD), and obtained the global ISO/IEC 17043:2023 accreditation—the first organisation globally to achieve this in camel disease Abdi Mohamed, Director of the Biosecurity Affairs Division at ADAFSA, underlined that the Reference Centre represents a realisation of UAE leadership's vision to preserve cultural heritage and bolsters food security through state-of-the-art science. She emphasised: 'We are proud that the UAE is the first nation in the world to host a WOAH‑accredited centre dedicated to camel diseases, underlining our global leadership in veterinary diagnostics and biosecurity.'She added that the centre plays a vital role in strengthening regional and international cooperation and supports the UAE's efforts in achieving food security and safeguarding animal resources. This aligns with the UAE's strategic vision for sustainable noted that the UAE and Abu Dhabi took the initiative to adopt the Scientific Commission for Animal Diseases' proposal during meetings held in Abu Dhabi and Italy in 2014–2015, which called for the establishment of a regional centre specialising in camel diseases in the Middle East. This initiative aimed to bridge knowledge gaps, enhance diagnostic capabilities, conduct epidemiological research, and facilitate knowledge May 2022, these efforts culminated in the official recognition of the Collaborating Centre for Camel Diseases by the World Organisation for Animal Health (WOAH), making it the world's first specialised centre of its kind, headquartered in Abu Dhabi, and providing diagnostic and advisory services regionally and confirmed that the centre is equipped with the latest diagnostic technologies, including advanced molecular biology tools, full and partial genome sequencing, bioinformatics, and facilities for cultivating high-risk pathogens. It also houses a biobank and camel-specific pathological anatomy capabilities, allowing for the collection of high-quality laboratory infrastructure supports early detection and identification of novel, emerging, or epidemic pathogens—strengthening national biosecurity and food safety systems and enhancing the country's emergency preparedness and response line with the One Health approach, Abdi pointed out the centre's pivotal role in combating antimicrobial resistance (AMR), through antibiotic susceptibility testing and contributions to peer-reviewed scientific publications on AMR. It also manages a dedicated biobank of resistant microbial isolates. The centre conducts annual awareness campaigns and participates in global partnerships, such as the UAE–UK Biosecurity Alliance, further strengthening its position as a strategic partner in advancing global also highlighted the centre's strong track record in global scientific research, having published over 30 papers in leading peer-reviewed journals. The centre has issued an atlas and a specialised reference book on camel diseases and established the Camel Health Network for the Middle East (CAMNET) to foster regional cooperation and training. To date, over 500 trainees from countries in the region have benefitted. Among its most notable contributions, the centre made a groundbreaking discovery by identifying the Wesselsbron virus as a potential cause of mysterious camel deaths in Ethiopia—further affirming the UAE's global leadership in diagnostics and biosecurity.
Al Etihad
a day ago
- Al Etihad
Best of ASCO UAE Conference opens in Abu Dhabi with focus on oncology
21 June 2025 15:53 ABU DHABI (WAM)The third edition of the Best of ASCO UAE Conference opened Saturday in Abu by SEHA, part of the PureHealth Group, in collaboration with Tawam Hospital, the event is taking place at Dusit Thani Hotel and continues until Sunday, bringing together a distinguished line-up of oncology experts from around the under licence from the American Society of Clinical Oncology (ASCO), the conference features more than 70 international, regional and local speakers, including oncology leaders from across the Gulf Cooperation Council and the programme includes over 70 scientific papers that have significantly influenced oncology treatment strategies this Julie Gralow, Chief Medical Officer and Executive Vice President of ASCO, told the Emirates News Agency (WAM) that the annual ASCO meeting highlighted key developments, including the use of circulating tumour DNA for diagnosis and the role of artificial intelligence in supporting pathologists with more accurate tumour emphasised the importance of healthy lifestyle habits in improving patient outcomes, citing a recent randomised study that found regular exercise following a colon cancer diagnosis led to reduced recurrence and mortality rates. She underscored the benefits of combining physical activity with a balanced diet and weight loss to enhance treatment also highlighted rapid advances in immunotherapy, particularly in antibody-drug conjugates and immune checkpoint inhibitors, which are now being used in new therapeutic indications and earlier stages of the subject of precision medicine, Gralow explained that the approach aims to identify molecular mutations that transform cells into cancerous forms and to develop treatments that precisely target those mutations. Many such targeted therapies have demonstrated efficacy in treating abnormal cancer-causing Khalid Saeed Balaraj, Chair of the Oncology Centre at Tawam Hospital, and Vice-Chair of the Conference, said the event includes more than seven specialist scientific workshops designed for junior doctors. These sessions aim to equip them for future roles in cancer care and provide valuable opportunities for direct engagement with leading international oncology discussed the emergence of new drugs that have proven effective against various cancers, noting that the conference will explore the potential for incorporating these treatments into formal care protocols, with particular emphasis on advances in treating breast cancer in also pointed to the breakthrough progress in immunotherapies and targeted therapies, which accurately attack tumours while preserving healthy surrounding added that modern medical care is increasingly based on developing individualised treatment plans tailored to each patient's unique biological and molecular profile. This approach can result in different treatment strategies for two patients with the same diagnosis, depending on their respective responses to treatment. He noted that ASCO organises an annual international conference attended by leading oncology scientists and researchers from around the world. Mouza Al Amri, Consultant Breast Surgeon and Acting Director of Breast Cancer Care Centre at Tawam Hospital, announced during the conference the launch of the Emirates Society of Radiation Oncology (ESRO). Based in Abu Dhabi, the society will focus on patient care, continuing medical education in oncology, radiation therapy and cancer surgery. She confirmed that the society's operations officially commenced on Saturday.
Al Etihad
2 days ago
- Al Etihad
UAE, Republic of Korea explore prospects for medical cooperation in radiation oncology
21 June 2025 14:12 ABU DHABI (WAM)The Medical Korea 2025 in the UAE symposium was held Saturday in Abu Dhabi, jointly organised by the Embassy of the Republic of Korea and the Korea Health Industry Development Institute (KHIDI), under the theme, 'New Horizons in Radiation Therapy: Particle Beam Therapy'.The event brought together a wide range of international specialists and experts in the field of radiation oncology and was hosted at Le Royal Meridien Abu symposium aimed to advance scientific and clinical cooperation between the UAE and the Republic of Korea, and to strengthen academic exchange in the latest cancer treatment technologies, particularly proton therapy, and carbon ion initiative comes in response to the growing global demand for innovative and effective medical solutions to combat the rising challenges of cancer, and underscores the shared commitment of both countries to advancing precision medicine and high-quality patient the beginning of the event, Park Jong Kyoung, Minister and Consul General of the Embassy of the Republic of Korea to the UAE delivered the keynote address. In his remarks, he cited statistics from the World Health Organisation (WHO), highlighting that more than 20 million people around the world are diagnosed with cancer each year, and 10 million lives are lost to the disease said that the number of cancer cases is projected to surpass 35 million per year within the next 25 years. 'Cancer, one of the greatest threats to humanity, remains a leading cause of death in both Korea and the UAE. Medical professionals in both countries are working on the task of curing cancer,' he stressed that this alarming figure underscores the need for unified scientific and medical efforts between the two countries to confront this shared global health indicated, "Korea is actively applying world-class advanced radiation technologies in clinical practice, including proton therapy and carbon ion therapy, which are the focus of today's event. I understand that the UAE is also making significant efforts to guarantee a healthy life free from the burden of cancer as demonstrated by its recent decision to introduce carbon ion accelerator facility."He also highlighted the depth of the strategic partnership between the Republic of Korea and the UAE, which began with the Barakah Nuclear Power Plant project in 2009. "Korea and the UAE have built a multifaceted partnership. I hope that the strong partnership between the two countries, which has been steadily solidified in the four key sectors of nuclear, energy, defence, and investment, will continue to expand into the healthcare sector as well," he concluded.
